Neurocrine Biosciences NBIX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's total current assets?
- Neurocrine Biosciences (NBIX) reported total current assets of $2.44B in Q1 2026.
- How has Neurocrine Biosciences's total current assets changed year-over-year?
- Neurocrine Biosciences's total current assets increased by 48.7% year-over-year, from $1.64B to $2.44B.
- What is the long-term trend for Neurocrine Biosciences's total current assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's total current assets has grown at a 19.9% compound annual growth rate (CAGR), from $1.02B to $2.52B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.